Distinctive symptoms
Register , to see more distinctive signs of diseases and studies 100% —
Register , to see more distinctive signs of diseases and studies — 100%
cervical canal stenosis
95%
—
fetal hypoxia —
60%
uterine atresia
89%
—
burning on the labia —
60%
hematometer
88%
—
acute vaginitis —
54%
hematosalpinx
83%
—
suffocating —
52%
pyometra
55%
—
chorioamnionitis —
52%
piosalpinx
55%
—
uterine hypoplasia —
50%
abnormalities of uterine development
46%
—
vaginal discharge in girls —
50%
ascherman syndrome
46%
—
redness of the labia —
49%
endocervicitis
42%
—
pulls the lower back —
49%
appendages of the uterus
42%
—
consequences of childbirth —
48%
hypertrophy of the uterine body
40%
—
threat of miscarriage —
47%
lack of menstruation
40%
—
itching of the labia —
47%
intrauterine septum
40%
—
pregnancy complications —
46%
delay menstruation
35%
—
hypoxia —
46%
appendages of uterus are painful
34%
—
vaginitis —
46%
uterine infertility
33%
—
microinfarction —
46%
cervical cancer
33%
—
blood diseases —
45%
rupture of the uterus
32%
—
redness of the vulva —
44%
spotting from the uterus
32%
—
violation of uteroplacental blood flow —
44%
stopped menstruation
32%
—
vaginal —
42%
cervical pregnancy
32%
—
intrauterine infection —
41%
uterine cancer
31%
—
premature birth —
39%
chlamydia
31%
—
vaginal swelling —
38%
monthly painful
31%
—
mental retardation —
38%
consequences of herpes
30%
—
up circulatory disorders —
38%
nausea
30%
—
postpartum endometritis —
38%
removal of the uterus
30%
—
respiratory syncytial infection —
37%
fainting from pain
29%
—
burning of the vulva —
37%
pain in the bladder
29%
—
urethral syndrome —
37%
pain in the side
28%
—
worse pregnancy —
36%
medical abortion
28%
—
discomfort when urinating —
36%
uterine tumor
27%
—
there are no complaints —
36%
infertility female
27%
—
underdevelopment —
35%
pain in the uterus
60%
32%
tropical malaria —
34%
syphilis
25%
—
general intoxication syndrome —
34%
stretching
25%
—
deterioration postpartum —
34%
vacuum
25%
—
abdominal pain —
33%
fainting
24%
—
shift of leukocyte formula to left —
33%
painful appearance
24%
—
parvovirus infection —
33%
lymphosarcoma
24%
—
early aging —
33%
caution
24%
—
reduction of the number of movements (oligokinesia) —
32%
pain in the intestines
23%
—
scarlet —
32%
disorders of consciousness
23%
—
streptococcal pneumonia —
32%
periods of exacerbation
22%
—
convulsions pain —
32%
metabolic disorder
22%
—
discharge from the genital tract —
32%
cancer
21%
—
intoxication —
31%
control issues
21%
—
magnesia —
31%
strong man
21%
—
necrosis —
31%
consequences of injuries
21%
—
swelling —
30%
diseases of the gastrointestinal tract
20%
—
lymphocytosis —
30%
acute pain
20%
—
better lying —
30%
injury
19%
—
alert —
30%
consequences of taking medications
19%
—
abdominal discomfort —
30%
intra-phase infections
45%
27%
death of the child —
30%
vulvitis
45%
27%
burning itching —
30%
endometritis
41%
30%
lower abdominal pain —
29%
impaired uterine function
55%
45%
with reactive protein increased —
29%
childhood diseases —
29%
myxedema —
29%
burning of the skin —
29%
fidgety —
28%
pain in the groin area —
28%
vasculitis —
28%
immaturity —
28%
urination disorder —
28%
growth retardation —
27%
inflammatory infiltrate —
27%
bacterial pneumonia —
27%
cytomegalovirus infection —
27%
nervous excitability —
27%
need for movement —
27%
calcification —
27%
growth disorders in children —
27%
lower back pain —
27%
1 pregnancy —
27%
motor activity —
26%
myocardial infarction —
26%
deterioration during pregnancy —
26%
sensations in the legs —
25%
itchy skin —
25%
aids —
25%
protein with increased —
25%
back pain —
25%
burns —
24%
leukocytosis —
24%
patient is motionless —
24%
dystrophy —
24%
vascular tumor —
24%
pneumonia —
24%
thrombosis —
23%
palpitations —
23%
acute condition —
23%
lags behind in the development —
23%
stage of recovery —
22%
treatment with antibiotics —
22%
impaired lung function —
21%
consequences of operation —
21%
recovery period —
21%
pregnancy
36%
48%
consequences of infection
28%
36%
herpes
24%
26%
vulva infections
45%
47%
female pelvic organs
50%
52%
toxoplasmosis
29%
30%
oncology
19%
20%